247 related articles for article (PubMed ID: 17715137)
1. Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors.
Dicker IB; Samanta HK; Li Z; Hong Y; Tian Y; Banville J; Remillard RR; Walker MA; Langley DR; Krystal M
J Biol Chem; 2007 Oct; 282(43):31186-96. PubMed ID: 17715137
[TBL] [Abstract][Full Text] [Related]
2. Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
Dicker IB; Terry B; Lin Z; Li Z; Bollini S; Samanta HK; Gali V; Walker MA; Krystal MR
J Biol Chem; 2008 Aug; 283(35):23599-609. PubMed ID: 18577511
[TBL] [Abstract][Full Text] [Related]
3. The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitors.
Langley DR; Samanta HK; Lin Z; Walker MA; Krystal MR; Dicker IB
Biochemistry; 2008 Dec; 47(51):13481-8. PubMed ID: 18991395
[TBL] [Abstract][Full Text] [Related]
4. Processing of deoxyuridine mismatches and abasic sites by human immunodeficiency virus type-1 integrase.
Mazumder A; Pommier Y
Nucleic Acids Res; 1995 Aug; 23(15):2865-71. PubMed ID: 7659508
[TBL] [Abstract][Full Text] [Related]
5. Azido-containing diketo acid derivatives inhibit human immunodeficiency virus type 1 integrase in vivo and influence the frequency of deletions at two-long-terminal-repeat-circle junctions.
Svarovskaia ES; Barr R; Zhang X; Pais GC; Marchand C; Pommier Y; Burke TR; Pathak VK
J Virol; 2004 Apr; 78(7):3210-22. PubMed ID: 15016842
[TBL] [Abstract][Full Text] [Related]
6. Activity of recombinant HIV-1 integrase on mini-HIV DNA.
Cherepanov P; Surratt D; Toelen J; Pluymers W; Griffith J; De Clercq E; Debyser Z
Nucleic Acids Res; 1999 May; 27(10):2202-10. PubMed ID: 10219094
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase.
Espeseth AS; Felock P; Wolfe A; Witmer M; Grobler J; Anthony N; Egbertson M; Melamed JY; Young S; Hamill T; Cole JL; Hazuda DJ
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11244-9. PubMed ID: 11016953
[TBL] [Abstract][Full Text] [Related]
8. [Interactions of HIV-1 DNA heterocyclic bases with viral DNA].
Agapkina IuIu; Tashlitskiĭ VN; Deprez E; Brochon JC; Shugaliĭ AV; Mouscadet JF; Gottikh MB
Mol Biol (Mosk); 2004; 38(5):848-57. PubMed ID: 15554187
[TBL] [Abstract][Full Text] [Related]
9. Two-long terminal repeat (LTR) DNA circles are a substrate for HIV-1 integrase.
Richetta C; Thierry S; Thierry E; Lesbats P; Lapaillerie D; Munir S; Subra F; Leh H; Deprez E; Parissi V; Delelis O
J Biol Chem; 2019 May; 294(20):8286-8295. PubMed ID: 30971426
[TBL] [Abstract][Full Text] [Related]
10. The role of manganese in promoting multimerization and assembly of human immunodeficiency virus type 1 integrase as a catalytically active complex on immobilized long terminal repeat substrates.
Wolfe AL; Felock PJ; Hastings JC; Blau CU; Hazuda DJ
J Virol; 1996 Mar; 70(3):1424-32. PubMed ID: 8627659
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.
Hazuda DJ; Felock P; Witmer M; Wolfe A; Stillmock K; Grobler JA; Espeseth A; Gabryelski L; Schleif W; Blau C; Miller MD
Science; 2000 Jan; 287(5453):646-50. PubMed ID: 10649997
[TBL] [Abstract][Full Text] [Related]
12. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.
Esposito D; Craigie R
EMBO J; 1998 Oct; 17(19):5832-43. PubMed ID: 9755183
[TBL] [Abstract][Full Text] [Related]
13. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
[TBL] [Abstract][Full Text] [Related]
14. Probing HIV-1 integrase inhibitor binding sites with position-specific integrase-DNA cross-linking assays.
Johnson AA; Marchand C; Patil SS; Costi R; Di Santo R; Burke TR; Pommier Y
Mol Pharmacol; 2007 Mar; 71(3):893-901. PubMed ID: 17172465
[TBL] [Abstract][Full Text] [Related]
15. Integration requires a specific interaction of the donor DNA terminal 5'-cytosine with glutamine 148 of the HIV-1 integrase flexible loop.
Johnson AA; Santos W; Pais GC; Marchand C; Amin R; Burke TR; Verdine G; Pommier Y
J Biol Chem; 2006 Jan; 281(1):461-7. PubMed ID: 16257967
[TBL] [Abstract][Full Text] [Related]
16. Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: role of DNA backbone flexibility and an open catalytic site.
Johnson AA; Sayer JM; Yagi H; Patil SS; Debart F; Maier MA; Corey DR; Vasseur JJ; Burke TR; Marquez VE; Jerina DM; Pommier Y
J Biol Chem; 2006 Oct; 281(43):32428-38. PubMed ID: 16943199
[TBL] [Abstract][Full Text] [Related]
17. Development of a fluorescence-based HIV-1 integrase DNA binding assay for identification of novel HIV-1 integrase inhibitors.
Han YS; Xiao WL; Quashie PK; Mesplède T; Xu H; Deprez E; Delelis O; Pu JX; Sun HD; Wainberg MA
Antiviral Res; 2013 Jun; 98(3):441-8. PubMed ID: 23583286
[TBL] [Abstract][Full Text] [Related]
18. The HIV-1 integrase monomer induces a specific interaction with LTR DNA for concerted integration.
Pandey KK; Bera S; Grandgenett DP
Biochemistry; 2011 Nov; 50(45):9788-96. PubMed ID: 21992419
[TBL] [Abstract][Full Text] [Related]
19. The strand transfer oligonucleotide inhibitors of HIV-integrase.
Snásel J; Rosenberg I; Paces O; Pichová I
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):241-6. PubMed ID: 18608742
[TBL] [Abstract][Full Text] [Related]
20. Displacement of viral DNA termini from stable HIV-1 integrase nucleoprotein complexes induced by secondary DNA-binding interactions.
Pemberton IK; Buc H; Buckle M
Biochemistry; 1998 Feb; 37(8):2682-90. PubMed ID: 9485419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]